Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marilyne Labrie

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
The Journal of Clinical Investigation|May 1, 2024
Enhancing anticancer activity of macrophages through rational drug combinationsGordon B Mills, Marilyne Labrie
Cellular and Molecular Life Sciences : CMLS|November 28, 2012
Epigenetic regulation of mmp-9 gene expressionMarilyne Labrie, Yves St-Pierre
Clinical & Experimental Metastasis|December 18, 2024
Current preclinical models of brain metastasisZacharie Drouin, Flavie Lévesque, Korina Mouzakitis, et al.
International Journal of Oncology|January 24, 2014
Intracellular galectins in cancer cells: potential new targets for therapy (Review)Maria C Vladoiu, Marilyne Labrie, Yves St-Pierre
Molecular Neurobiology|May 30, 2013
Binding and repressive activities of apolipoprotein E3 and E4 isoforms on the human ApoD promoterLouis-Charles Levros, Marilyne Labrie, Cyndia Charfi, et al.
Plos One|August 23, 2013
Expression of galectin-7 is induced in breast cancer cells by mutant p53Carole G Campion, Marilyne Labrie, Geneviève Lavoie, et al.
Expert Review of Proteomics|April 25, 2022
Characterization of anticancer drug resistance by reverse-phase protein array: new targets and strategiesAnn M Cathcart, Hannah Smith, Marilyne Labrie, et al.
Clinical Immunology (Orlando, Fla.)|July 27, 2024
T peripheral helper (Tph) cells, a marker of immune activation in cancer and autoimmune disordersCelia Del Carmen Crespo Oliva, Marilyne Labrie, Hugues Allard-Chamard
Biochemical Society Transactions|May 8, 2020
Systems approach to rational combination therapy: PARP inhibitorsChaoyang Sun, Yong Fang, Marilyne Labrie, et al.
Plos One|May 3, 2014
The CCAAT/enhancer-binding protein beta-2 isoform (CEBPβ-2) upregulates galectin-7 expression in human breast cancer cellsCarole G Campion, Marilyne Labrie, Andrée-Anne Grosset, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
The Journal of Clinical Investigation|May 1, 2024
Enhancing anticancer activity of macrophages through rational drug combinationsGordon B Mills, Marilyne Labrie
Cellular and Molecular Life Sciences : CMLS|November 28, 2012
Epigenetic regulation of mmp-9 gene expressionMarilyne Labrie, Yves St-Pierre
Clinical & Experimental Metastasis|December 18, 2024
Current preclinical models of brain metastasisZacharie Drouin, Flavie Lévesque, Korina Mouzakitis, et al.
International Journal of Oncology|January 24, 2014
Intracellular galectins in cancer cells: potential new targets for therapy (Review)Maria C Vladoiu, Marilyne Labrie, Yves St-Pierre
Molecular Neurobiology|May 30, 2013
Binding and repressive activities of apolipoprotein E3 and E4 isoforms on the human ApoD promoterLouis-Charles Levros, Marilyne Labrie, Cyndia Charfi, et al.
Plos One|August 23, 2013
Expression of galectin-7 is induced in breast cancer cells by mutant p53Carole G Campion, Marilyne Labrie, Geneviève Lavoie, et al.
Expert Review of Proteomics|April 25, 2022
Characterization of anticancer drug resistance by reverse-phase protein array: new targets and strategiesAnn M Cathcart, Hannah Smith, Marilyne Labrie, et al.
Clinical Immunology (Orlando, Fla.)|July 27, 2024
T peripheral helper (Tph) cells, a marker of immune activation in cancer and autoimmune disordersCelia Del Carmen Crespo Oliva, Marilyne Labrie, Hugues Allard-Chamard
Biochemical Society Transactions|May 8, 2020
Systems approach to rational combination therapy: PARP inhibitorsChaoyang Sun, Yong Fang, Marilyne Labrie, et al.
Plos One|May 3, 2014
The CCAAT/enhancer-binding protein beta-2 isoform (CEBPβ-2) upregulates galectin-7 expression in human breast cancer cellsCarole G Campion, Marilyne Labrie, Andrée-Anne Grosset, et al.
Pageof 5